Susi Geiger

Le projet

Titre : Peak Pharma: Drugs, Value Extraction and Global Discontent in Pharmaceutical Markets

Mots-clés : Pharmaceutical markets, healthcare, market shaping, social movements, public good, digital health

Sélection de publication

• Bourgeron, Théo & Susi Geiger (2022): Building the weak hand of the state: Tracing the market boundaries of high pharmaceutical prices in France. New Political Economy 27(5), 837-850.      https://doi.org/10.1080/13563467.2022.2036115
• Geiger, Susi & Aisling McMahon (2022):  An institutional analysis of the landscape and proliferation of proposals for Global Vaccine Equity for COVID-19: Too Many Cooks or too many Recipes? Journal of Medical Ethics. https://doi.org/10.1136/medethics-2021-107684 
• Bourgeron, Théo & Susi Geiger (2022): “(De-)Assetising Pharmaceutical Patents: Patent Contestations Behind a Blockbuster Drug”. Economy & Society Vol. 51(1), 23-45 https://doi.org/10.1080/03085147.2022.1987752
• Geiger, Susi & Nicole Gross: “A tidal wave of inevitable data? Assetization in the consumer genetics testing industry“ Business & Society Vol. 60(3), 614-649.
   https://doi.org/10.1177/0007650319826307
• Geiger Susi (ed.) (2021): Healthcare Activism: Markets, Morals, and the Collective Good. Oxford University Press.